(Q21284816)

6

Francisco

Abad-Santos

1 reference

19 August 2022

Rocío Prieto-Pérez

1

Rocío

Prieto-Pérez

1 reference

19 August 2022

Teresa Cabaleiro

2

Teresa

Cabaleiro

1 reference

19 August 2022

Esteban Daudén

3

Esteban

Daudén

1 reference

19 August 2022

Dolores Ochoa

4

Dolores

Ochoa

1 reference

19 August 2022

Manuel Roman

5

Manuel

Roman

1 reference

Creative Commons Attribution 3.0 Unported

19 August 2022

language of work or name

English

0 references

publication date

2013

0 references

1 reference

2013

0 references

page(s)

613086

0 references

copyright license

start time

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Association analyses identify six new psoriasis susceptibility loci in the Chinese population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Identification of ZNF313/RNF114 as a novel psoriasis susceptibility gene

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Tofacitinib and other kinase inhibitors in the treatment of psoriasis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Advances in the discovery of selective JAK inhibitors

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Serum cytokines correlated with the disease severity of generalized pustular psoriasis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Effect of IL-17A blockade with secukinumab in autoimmune diseases

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Role of IL-17 in psoriasis and psoriatic arthritis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Phosphospecific flow cytometry for pharmacodynamic drug monitoring: analysis of the JAK-STAT signaling pathway

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Targeting JAK3 in kidney transplantation: current status and future options

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

The genetics of psoriatic arthritis: lessons from genome-wide association studies

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Variants in linkage disequilibrium with the late cornified envelope gene cluster deletion are associated with susceptibility to psoriatic arthritis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Genetics of psoriasis and psoriatic arthritis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Anti-p40 antibodies ustekinumab and briakinumab: blockade of interleukin-12 and interleukin-23 in the treatment of psoriasis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Vitamin D endocrine system and psoriasis vulgaris--review of the literature.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Genetic evidence for involvement of the IL23 pathway in Thai psoriatics

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Multiple Loci within the major histocompatibility complex confer risk of psoriasis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Anti-TNF agents for the treatment of psoriasis.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Unraveling the genetics of complex diseases: susceptibility genes for rheumatoid arthritis and psoriasis.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

CP-690550, a JAK3 inhibitor as an immunosuppressant for the treatment of rheumatoid arthritis, transplant rejection, psoriasis and other immune-mediated disorders

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Polymorphisms of the IL12B and IL23R genes are associated with psoriasis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

A study of ApaI and TaqI genotypes of the vitamin D receptor in Egyptian patients with psoriasis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Psoriasis is associated with increased beta-defensin genomic copy number

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Biological therapy of psoriasis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Deletion of LCE3C and LCE3B is a susceptibility factor for psoriatic arthritis: a study in Spanish and Italian populations and meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Apremilast mechanism of action and application to psoriasis and psoriatic arthritis

30 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Cytokine gene polymorphisms in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Apolipoprotein epsilon4 allele is associated with psoriasis severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Variants in MHC, LCE and IL12B have epistatic effects on psoriasis risk in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Promoter Polymorphisms of the Genes Encoding Tumor Necrosis Factor-α and Interleukin-1β are Associated with Different Subtypes of Psoriasis Characterized by Early and Late Disease Onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

No Association between Polymorphisms in the Interleukin-15 Gene and Early-Onset Psoriasis in a UK Cohort Suggests Heterogeneity for this Susceptibility Locus Identified in Chinese Psoriasis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Association of TNF -238 and -308 Promoter Polymorphisms with Psoriasis Vulgaris and Psoriatic Arthritis but not with Pustulosis Palmoplantaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

CTLA-4 gene polymorphisms and natural soluble CTLA-4 protein in psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Distribution of the CTLA-4 single nucleotide polymorphisms CT60G>A and +49A>G in psoriasis vulgaris patients and control individuals from a Polish Caucasian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Risk variants for psoriasis vulgaris in a large case–control collection and association with clinical subphenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

No associations of CTLA-4 and ICAM-1 polymorphisms with psoriasis in the Korean population

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3771250

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

29 November 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

Polymorphisms of tumor necrosis factor (TNF) α and β genes in Korean patients with psoriasis

21 January 2018

1 reference

12 December 2020

Replication of association between interleukin-23 receptor (IL-23R) and its ligand (IL-12B) polymorphisms and psoriasis in the Chinese Han population

1 reference

12 December 2020

Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans

1 reference

12 December 2020

[Enlightenment from genome-wide association study to genetics of psoriasis]

1 reference

12 December 2020

Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking.

1 reference

12 December 2020

Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals

1 reference

12 December 2020

Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cells

1 reference

12 December 2020

Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21

1 reference

12 December 2020

Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients

1 reference

12 December 2020

STAT4 gene polymorphism is associated with psoriasis in the genetically homogeneous population of Crete, Greece

1 reference

12 December 2020

Tumor necrosis factor-alpha gene polymorphism in psoriasis

1 reference

12 December 2020

Detailed genetic characterization of the interleukin-23 receptor in psoriasis

1 reference

12 December 2020

Pharmacogenetic analysis of TNF, TNFRSF1A, and TNFRSF1B gene polymorphisms and prediction of response to anti-TNF therapy in psoriasis patients in the Greek population

1 reference

12 December 2020

Associations of IL-2 and IL-4 gene polymorphisms with psoriasis in the Korean population

1 reference

12 December 2020

Variants in the 5q31 cytokine gene cluster are associated with psoriasis

1 reference

12 December 2020

Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism

1 reference

12 December 2020

Combined analysis of polymorphisms of the tumor necrosis factor-alpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis

1 reference

12 December 2020

Genetic Variants of the IL-23R Pathway: Association with Psoriatic Arthritis and Psoriasis Vulgaris, but No Specific Risk Factor for Arthritis

1 reference

12 December 2020

Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study

1 reference

12 December 2020

Apolipoprotein E gene polymorphism in psoriasis

1 reference

12 December 2020

TNF-alpha gene promoter -238G>A and -308G>A polymorphisms alter risk of psoriasis vulgaris: a meta-analysis

1 reference

12 December 2020

A single nucleotide polymorphism of MHC region is associated with subphenotypes of Psoriasis in Chinese population

1 reference

12 December 2020

Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population

1 reference

12 December 2020

The Association between the IL-20 –1723C→G Allele on the 1q Chromosome and Psoriasis Triggered or Exacerbated by an Upper Respiratory Tract Infection in the Chinese Han Population

1 reference

12 December 2020

Polymorphisms in interleukin-15 gene on chromosome 4q31.2 are associated with psoriasis vulgaris in Chinese population

1 reference

12 December 2020

IFN-gamma promoter gene polymorphism in psoriasis vulgaris

1 reference

12 December 2020

Interferon-18 gene polymorphism -137 G/C is associated with susceptibility to psoriasis vulgaris but not with atopic dermatitis in Japanese patients

1 reference

12 December 2020

Further association analysis of chr 6q22-24 suggests a role of IL-20RA polymorphisms in psoriasis

1 reference

12 December 2020

Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study

1 reference

12 December 2020

Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis

1 reference

12 December 2020

Anti-interleukin-17 monoclonal antibody ixekizumab in psoriasis

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F613086

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1155/2013/613086

0 references

Fatcat ID

release_p74ag63nwzef5dfvqsa4u2aphy

0 references

PMC publication ID

3771250

0 references